Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Psychological treatment for patients with chronic kidney disease

Official title: Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Run by Universidad Europea de Madrid · NCT06109493 · Data updated 2026-11-12

This study is testing whether Acceptance and Commitment Therapy can help improve the mental well-being of people with chronic kidney disease who are on hemodialysis.

More Depression trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment104 (estimated)
SponsorUniversidad Europea de Madrid
Academic / other
Locations1 site (Madrid)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedDecember 31, 2025
Study endsJune 30, 2026
Registry record updatedApril 23, 2025
Trial IDNCT06109493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with chronic kidney disease on hemodialysis for at least 3 months and experiencing moderate to severe depression.

Probably not a fit

Patients with severe mental disorders, cognitive impairments, or those currently receiving other psychological treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficacy of Acceptance and Commitment Therapy (ACT) as a psychological intervention for patients suffering from chronic kidney disease. Participants will be assessed for eligibility and then randomly assigned to either a control group or an intervention group receiving 8 sessions of ACT. The effectiveness of the treatment will be evaluated using self-report instruments before and after the intervention, as well as at a 3-month follow-up. The study aims to provide insights into the psychological well-being of patients undergoing hemodialysis.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the mental health and quality of life for patients with chronic kidney disease.

How similar studies have gone: While the use of ACT in chronic illness management is gaining attention, this specific application in chronic kidney disease is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with chronic kidney disease on haemodialysis
* Older than 18 years-old
* At least 3 months on haemodialysis
* HADS Global Scale Score ≥14

Exclusion Criteria:

* Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
* Antidepressant drugs consume
* Insufficient understanding of Spanish.
* Patients who are in the Advanced Chronic Kidney Disease Unit
* Receiving other psychological treatment

Where it's running

  • Fundación Renal Iñigo Alvarez de Toledo
    Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.